Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

6.20
+1.0319.92%
Post-market: 6.12-0.0800-1.29%19:59 EDT
Volume:52.41M
Turnover:445.04M
Market Cap:4.77M
PE:-0.33
High:11.20
Open:8.25
Low:5.50
Close:5.17
52wk High:137.96
52wk Low:4.56
Shares:770.10K
Float Shares:533.80K
Volume Ratio:1,111.30
T/O Rate:9817.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.7000
EPS(LYR):-18.7500
ROE:-1888.70%
ROA:-159.56%
PB:-13.05
PE(LYR):-0.33

Loading ...

Pharmala Biotech - to Manufacture Gmp-grade Ala-002 for Jupiter Under Separate Supply Agreement

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Development and Regulatory Milestones up to $23.33 Mln Including $20 Mln for FDA Approval

THOMSON REUTERS
·
Jul 21

Pharmala Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to Ala-002

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Upfront Payment of $3.33 Mln: $1.50 Mln Cash, $1.83 Mln in Jupiter Stock

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Deal Valued up to $100 Mln Including $3.33 Mln Upfront and Milestones Plus Royalties

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - to Receive 3% Royalty on U.S. Net Sales After Third Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board

Reuters
·
Jul 07

Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson

THOMSON REUTERS
·
Jul 07

Jupiter Neurosciences Appoints Tomas J. Philipson to Board

Reuters
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 29

Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jun 27

Jupiter Neurosciences Announces Board Member Resignation and Vacancy

TIPRANKS
·
Jun 22

Jupiter Neurosciences director Allison Brady resigns from board, committees

Reuters
·
Jun 22

Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator

Reuters
·
Jun 18

Jupiter Neurosciences Promotes Silva to COO and President

TIPRANKS
·
Jun 06

Jupiter Neurosciences commences patient enrollment in RESET trial

TIPRANKS
·
May 27

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease

THOMSON REUTERS
·
May 27

Jupiter Neurosciences closes $2 million registered direct offering

Reuters
·
May 22

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

THOMSON REUTERS
·
May 22

Jupiter Neurosciences Inc - Files for Offering of 7.14 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
May 21